{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T08:18:58Z","timestamp":1779351538817,"version":"3.51.4"},"reference-count":61,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K22 AI110573-01"],"award-info":[{"award-number":["K22 AI110573-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01AI123224"],"award-info":[{"award-number":["1R01AI123224"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Physiol."],"DOI":"10.3389\/fphys.2016.00214","type":"journal-article","created":{"date-parts":[[2016,6,13]],"date-time":"2016-06-13T23:28:54Z","timestamp":1465860534000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["The Therapeutic Potential of Targeting Cytokine Alarmins to Treat Allergic Airway Inflammation"],"prefix":"10.3389","volume":"7","author":[{"given":"Chandler B.","family":"Sy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark C.","family":"Siracusa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2016,6,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.jaci.2008.10.022","article-title":"CD34+ hemopoietic progenitor cells are potent effectors of allergic inflammation","volume":"123","author":"Allakhverdi","year":"2009","journal-title":"J. Allergy Clin. Immunol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1084\/jem.20050199","article-title":"A role for TSLP in the development of inflammation in an asthma model","volume":"202","author":"Al-Shami","year":"2005","journal-title":"J. Exp. Med."},{"key":"B3","author":"Asthma","year":"2015a"},{"key":"B4","author":"Asthma","year":"2015b","journal-title":"FastStats"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.jaci.2007.07.051","article-title":"Blocking IL-25 prevents airway hyperresponsiveness in allergic asthma","volume":"120","author":"Ballantyne","year":"2007","journal-title":"J. Allergy Clin. Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"256r","DOI":"10.1126\/scitranslmed.3009124","article-title":"Rhinovirus-induced IL-25 in asthma exacerbation drives type 2 immunity and allergic pulmonary inflammation","volume":"6","author":"Beale","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1002\/eji.201041033","article-title":"IL-33-activated dendritic cells are critical for allergic airway inflammation","volume":"41","author":"Besnard","year":"2011","journal-title":"Eur. J. Immunol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1183\/09031936.00083406","article-title":"Air pollution and development of asthma, allergy and infections in a birth cohort","volume":"29","author":"Brauer","year":"2007","journal-title":"Eur. Respir. J."},{"key":"B9","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.jaci.2009.01.062","article-title":"Advances in environmental and occupational disorders in 2008","volume":"123","author":"Bush","year":"2009","journal-title":"J. Allergy Clin. Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1136\/bmj.e2734","article-title":"Asthma","volume":"344","author":"Busse","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1476-5381.2011.01216.x","article-title":"\u03b22-adrenoceptor agonists: current and future direction","volume":"163","author":"Cazzola","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/S0091-6749(98)70165-4","article-title":"Difficult-to-control asthma: clinical characteristics of steroid-insensitive asthma","volume":"101","author":"Chan","year":"1998","journal-title":"J. Allergy Clin. Immunol."},{"key":"B13","first-page":"10","article-title":"Pharmacological agents used to treat asthma","volume":"15","author":"Chung","year":"2003","journal-title":"Change"},{"key":"B14","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1146\/annurev.immunol.22.012703.104716","article-title":"Asthma: mechanisms of disease persistence and progression","volume":"22","author":"Cohn","year":"2004","journal-title":"Annu. Rev. Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1056\/NEJMc1112234#SA3","article-title":"Lebrikizumab treatment in adults with asthma","volume":"365","author":"Corren","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/j.rmed.2005.11.020","article-title":"Systemic side effects of inhaled corticosteroids in patients with asthma","volume":"100","author":"Dahl","year":"2006","journal-title":"Respir. Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1093\/ckj\/sfv046","article-title":"Treatment of asthma with antileukotrienes: first line or last resort therapy?","volume":"533","author":"Dahl\u00e9n","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1136\/adc.2003.014365","article-title":"The effect of asthma and its treatment on growth","volume":"89","author":"Doull","year":"2004","journal-title":"Arch. Dis. Child."},{"key":"B19","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/9680","article-title":"Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment","volume":"22","author":"Drazen","year":"1999","journal-title":"Nat. Genet."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1183\/09031936.06.00043005","article-title":"Low-dose inhaled and nasal corticosteroid use and the risk of cataracts","volume":"27","author":"Ernst","year":"2006","journal-title":"Eur. Respir. J."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1056\/NEJMoa1402895","article-title":"Effects of an anti-TSLP antibody on allergen-induced asthmatic responses","volume":"370","author":"Gauvreau","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1289\/ehp.8380","article-title":"How exposure to environmental tobacco smoke, outdoor air pollutants, and increased pollen burdens influences the incidence of asthma","volume":"114","author":"Gilmour","year":"2006","journal-title":"Environ. Health Perspect."},{"key":"B24","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.immuni.2011.12.020","article-title":"Lung natural helper cells are a critical source of Th2 cell-type cytokines in protease allergen-induced airway inflammation","volume":"36","author":"Halim","year":"2012","journal-title":"Immunity"},{"key":"B25","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1146\/annurev.physiol.010908.163200","article-title":"Immunobiology of asthma","volume":"71","author":"Hamid","year":"2009","journal-title":"Annu. Rev. Physiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.jaci.2009.04.018","article-title":"A thymic stromal lymphopoietin gene variant is associated with asthma and airway hyperresponsiveness","volume":"124","author":"He","year":"2009","journal-title":"J. Allergy Clin. Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1183\/09031936.00087506","article-title":"Local genetic and environmental factors in asthma disease pathogenesis: chronicity and persistence mechanisms","volume":"29","author":"Holgate","year":"2007","journal-title":"Eur. Respir. J."},{"key":"B28","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.jaci.2012.06.034","article-title":"IL-13 in asthma and allergic disease: asthma phenotypes and targeted therapies","volume":"130","author":"Ingram","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1164\/ajrccm.162.1.9907092","article-title":"The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma","volume":"162","author":"Israel","year":"2000","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1084\/jem.20051135","article-title":"TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand","volume":"202","author":"Ito","year":"2005","journal-title":"J. Exp. Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1164\/rccm.200802-309OC","article-title":"Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children","volume":"178","author":"Jackson","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1056\/NEJMoa1203229","article-title":"Effect of inhaled glucocorticoids in childhood on adult height","volume":"367","author":"Kelly","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e53","DOI":"10.1542\/peds.2007-3381","article-title":"Effect of long-term corticosteroid use on bone mineral density in children: a prospective longitudinal assessment in the childhood Asthma Management Program (CAMP) study","volume":"122","author":"Kelly","year":"2008","journal-title":"Pediatrics"},{"key":"B34","doi-asserted-by":"publisher","first-page":"170ra116","DOI":"10.1126\/scitranslmed.3005374","article-title":"TSLP elicits IL-33-independent innate lymphoid cell responses to promote skin inflammation","volume":"5","author":"Kim","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.jaci.2006.12.669","article-title":"Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma","volume":"119","author":"Kusel","year":"2007","journal-title":"J. Allergy Clin. Immunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1126\/science.1090010","article-title":"Characterization of a common susceptibility locus for asthma-related traits","volume":"304","author":"Laitinen","year":"2004","journal-title":"Science"},{"key":"B37","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/S1081-1206(10)62170-9","article-title":"Omalizumab is effective in the long-term control of severe allergic asthma","volume":"91","author":"Lanier","year":"2003","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1016\/S0140-6736(00)03496-6","article-title":"Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response","volume":"356","author":"Leckie","year":"2000","journal-title":"Lancet"},{"key":"B39","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.bbrc.2009.06.008","article-title":"Anti-IL-33 antibody treatment inhibits airway inflammation in a murine model of allergic asthma","volume":"386","author":"Liu","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B40","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/nri2870","article-title":"Functions of T cells in asthma: more than just TH2 cells","volume":"10","author":"Lloyd","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.immuni.2012.08.015","article-title":"The transcription factor GATA3 is essential for the function of human type 2 innate lymphoid cells","volume":"37","author":"Mj\u00f6sberg","year":"2012","journal-title":"Immunity"},{"key":"B20","volume-title":"Expert Panel Report 3 (EPR 3): Guidelines for the Diagnosis and Management of Asthma.","author":"National Heart Lung Blood Institute","year":"2007"},{"key":"B42","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1086\/427763","article-title":"Fine mapping and positional candidate studies identify HLA-G as an asthma susceptibility gene on chromosome 6p21","volume":"76","author":"Nicolae","year":"2005","journal-title":"Am. J. Hum. Genet."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1056\/NEJMoa1403290","article-title":"Mepolizumab treatment in patients with severe eosinophilic asthma","volume":"371","author":"Ortega","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nri2735","article-title":"How are TH2-type immune responses initiated and amplified?","volume":"10","author":"Paul","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/nrd3792","article-title":"The potential of biologics for the treatment of asthma","volume":"11","author":"Pelaia","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"B46","first-page":"851","article-title":"Safety of inhaled corticosteroids in the treatment of persistent asthma","volume":"98","author":"Peters","year":"2006","journal-title":"J. Natl. Med. Assoc."},{"key":"B47","doi-asserted-by":"publisher","first-page":"5094","DOI":"10.4049\/jimmunol.0802387","article-title":"Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells","volume":"183","author":"Prefontaine","year":"2009","journal-title":"J. Immunol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1084\/jem.20130351","article-title":"A role for IL-25 and IL-33\u2013driven type-2 innate lymphoid cells in atopic dermatitis","volume":"210","author":"Salimi","year":"2013","journal-title":"J. Exp. Med."},{"key":"B49","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1136\/thorax.55.suppl_2.S28","article-title":"Variant LTC(4) synthase allele modifies cysteinyl leukotriene synthesis in eosinophils and predicts clinical response to zafirlukast","author":"Sampson","year":"2000","journal-title":"Thorax 55"},{"key":"B50","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/nature10329","article-title":"TSLP promotes interleukin-3-independent basophil haematopoiesis and type 2 inflammation","volume":"477","author":"Siracusa","year":"2011","journal-title":"Nature"},{"key":"B51","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1183\/09031936.01.00092101","article-title":"The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics","volume":"18","author":"Soler","year":"2001","journal-title":"Eur. Respir. J."},{"key":"B52","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/ni805","article-title":"Human epithelial cells trigger dendritic cell\u2013mediated allergic inflammation by producing TSLP","volume":"3","author":"Soumelis","year":"2002","journal-title":"Nat. Immunol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"3641","DOI":"10.4049\/jimmunol.1200461","article-title":"Epithelial cell-derived IL-25, but not Th17 cell-derived IL-17 or IL-17F, is crucial for murine asthma","volume":"189","author":"Suzukawa","year":"2012","journal-title":"J. Immunol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1093\/hmg\/ddh149","article-title":"Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids","volume":"13","author":"Tantisira","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"B55","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/nri2257","article-title":"Discovering susceptibility genes for asthma and allergy","volume":"8","author":"Vercelli","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.ophtha.2008.12.001","article-title":"Use of inhaled and oral corticosteroids and the long-term risk of cataract","volume":"116","author":"Wang","year":"2009","journal-title":"Ophthalmology"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1084\/jem.20070406","article-title":"IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC-activated Th2 memory cells","volume":"204","author":"Wang","year":"2007","journal-title":"J. Exp. Med."},{"key":"B58","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/sj.tpj.6500387","article-title":"Overview of the pharmacogenetics of asthma treatment","volume":"6","author":"Weiss","year":"2006","journal-title":"Pharmacogenomics J."},{"key":"B59","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/nm.2678","article-title":"Asthma phenotypes: the evolution from clinical to molecular approaches","volume":"18","author":"Wenzel","year":"2012","journal-title":"Nat. Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1002\/eji.201142018","article-title":"Pulmonary innate lymphoid cells are major producers of IL-5 and IL-13 in murine models of allergic asthma","volume":"42","author":"Wolterink","year":"2012","journal-title":"Eur. J. Immunol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"8183","DOI":"10.4049\/jimmunol.174.12.8183","article-title":"Thymic stromal lymphopoietin expression is increased in asthmatic airways and correlates with expression of Th2-attracting chemokines and disease severity","volume":"174","author":"Ying","year":"2005","journal-title":"J. Immunol."}],"container-title":["Frontiers in Physiology"],"original-title":[],"deposited":{"date-parts":[[2016,7,6]],"date-time":"2016-07-06T09:48:10Z","timestamp":1467798490000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fphys.2016.00214\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,14]]},"references-count":61,"URL":"https:\/\/doi.org\/10.3389\/fphys.2016.00214","relation":{},"ISSN":["1664-042X"],"issn-type":[{"value":"1664-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,14]]}}}